Tempus AI (NASDAQ:TEM) Posts Quarterly Earnings Results

Tempus AI (NASDAQ:TEM) posted its quarterly earnings results on Monday. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.18), Zacks reports.

Tempus AI Trading Up 2.2 %

NASDAQ TEM traded up $1.48 during midday trading on Monday, hitting $69.57. The company had a trading volume of 18,382,878 shares, compared to its average volume of 14,454,233. Tempus AI has a twelve month low of $22.89 and a twelve month high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The firm has a 50-day moving average price of $50.29 and a 200-day moving average price of $51.82.

Wall Street Analysts Forecast Growth

TEM has been the topic of several analyst reports. Wolfe Research assumed coverage on shares of Tempus AI in a report on Friday, December 13th. They issued an “outperform” rating and a $60.00 target price on the stock. Bank of America increased their price target on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Needham & Company LLC reiterated a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a report on Tuesday, January 14th. Guggenheim assumed coverage on Tempus AI in a research note on Monday, December 9th. They set a “buy” rating and a $74.00 target price for the company. Finally, Loop Capital reduced their price target on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a report on Tuesday, January 14th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $58.55.

Insider Buying and Selling

In related news, CAO Ryan M. Bartolucci sold 13,770 shares of the company’s stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $60.00, for a total transaction of $826,200.00. Following the transaction, the chief accounting officer now directly owns 57,237 shares of the company’s stock, valued at approximately $3,434,220. This represents a 19.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Eric P. Lefkofsky sold 476,209 shares of the business’s stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the sale, the chief executive officer now directly owns 6,502,643 shares of the company’s stock, valued at approximately $324,091,727.12. The trade was a 6.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 2,583,467 shares of company stock valued at $130,542,311 over the last quarter.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.